Carfilzomib’s mechanism of action

Carfilzomib (Carfilzomib) is a proteasome inhibitor mainly used to treat multiple myeloma (Multiple Myeloma) and other related blood cancers. Its mechanism of action involves interfering with the function of the proteasome, producing potent anticancer effects on cancer cells. Here is a detailed explanation of carfilzomib’s mechanism of action:

1.The importance of proteasomes: Proteasomes are subcellular organelles within cells that are responsible for degrading and breaking down intracellular proteins. This process is important because it helps maintain normal protein metabolism, dispose of harmful or unwanted proteins, and regulate key biological processes such as the cell cycle and apoptosis (programmed cell death).

2.The effects of carfilzomib: Carfilzomib prevents the normal degradation of proteins by inhibiting the protein degradation mechanism in the proteasome. This leads to the accumulation of proteins within cells, especially those that are abnormal or harmful, such as those that are overproduced in multiple myeloma.

3.The impact of cancer cells: Multiple myeloma is a malignant tumor that is often accompanied by abnormal plasma cell proliferation. These plasma cells produce abnormal proteins, leading to damage to the skeletal system, decreased immune function, anemia and other symptoms. Carfilzomib works by inducing the accumulation of abnormal proteins in multiple myeloma cells, ultimately leading to the death of these cancer cells.

4.Apoptosis: The effects of carfilzomib also include inducing apoptosis, which is a process of programmed cell death. By triggering apoptosis, it helps eliminate abnormal or cancerous cells to maintain normal cell ecological balance.

Carfilzomib has been launched in China and is included in medical insurance. Patients can purchase it domestically at a price of around 8,000 to 9,000 yuan. Please consult the local hospital pharmacy for specific prices. In foreign countries, the original drug of carfilzomib is mainly available, and the cheaper version is the European version of the original drug, which costs around 5,000. And the medicinal ingredients and efficacy are the same as those of domestic original medicines.